Nanoviricides (NNVC) Assets (2011 - 2026)

Nanoviricides has disclosed Assets across 16 years of filings, most recently posting $10.2 million for Q1 2026.

• In Q1 2026, Assets rose 1.86% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 1.86% YoY), while the FY2025 annual figure was $8.8 million, down 31.18% from the prior year.
• Assets came in at $10.2 million for Q1 2026 at Nanoviricides, down from $12.3 million in the prior quarter.
• In the past five years, Assets ranged from a high of $25.1 million in Q1 2022 to a low of $8.4 million in Q3 2025.
• Average Assets over 5 years is $14.9 million, with a median of $12.8 million recorded in 2024.
• Year-over-year, Assets tumbled 38.28% in 2024 and advanced 6.02% in 2025.
• Over 5 years, Assets stood at $20.3 million in 2022, then plunged by 34.09% to $13.4 million in 2023, then slipped by 13.67% to $11.6 million in 2024, then advanced by 6.02% to $12.3 million in 2025, then fell by 16.7% to $10.2 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $10.2 million in Q1 2026, $12.3 million in Q4 2025, and $8.4 million in Q3 2025.